Early coronary angioplasty for Acute Myocardial Infarction complicated by Cardiogenic Shock: Have novel therapies led to better results?

Journal of Invasive Cardiology

Volumn 12, Issue 12, 2000, Pages 597-604

  Moreno, Raúl ^a   García, Eulogio ^a   Abeytua, Manuel ^a   Soriano, Javier ^a   Acosta, Julio ^a   Pérez De Isla, Leopoldo ^a   López De Sá, Esteban ^a   Rubio, Rafael ^a   López Sendón, José ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Acute myocardial infarction; Angioplasty; Shock

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; FEMALE; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; SPAIN; STENT; SURVIVAL; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; SHOCK, CARDIOGENIC; SPAIN; STENTS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0034576856     PISSN: 10423931     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Rothbaum DA, Linnemeier TJ, Landin RJ, et al. Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: A 3-year experience. J Am Coll Cardiol 1987;10:264-272.
2. O'Neill WW, Brodie BR, Ivanhoe R, et al. Primary coronary angioplasty for acute myocardial infarction (the Primary Angioplasty registry). Am J Cardiol 1994;73:627-634.
3. Ellis SG, Topol EJ, Gallison L, et al. Predictors of success for coronary angioplasty performed for acute myocardial infarction. J Am Coll Cardiol 1988;12:1407-1415.
4. Bedotto JB, Kahn JK, Rutherford BD, et al. Failed direct coronary angioplasty for acute myocardial infarction: In-hospital outcome and predictors of death. J Am Coll Cardiol 1993;22:690-694.
5. van't Hof A, Liem A, Suryapranata H, et al. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction. Circulation 1998;97:2302-2306.
6. Lee L, Bates ER, Pitt B, et al. Percutaneous transluminal coronary angioplasty improves survival in acute myocardial infarction complicated by cardiogenic shock. Circulation 1988;78:1345-1351.
7. Lee L, Erbel R, Brown TM, et al. Multicenter registry of angioplasty therapy of cardiogenic shock: Initial and long-term survival. J Am Coll Cardiol 1991;17:599-603.
8. Hibbard MD, Holmes DR, Bailey KR, et al. Percutaneous transluminal coronary angioplasty in patients with cardiogenic shock. J Am Coll Cardiol 1992;19:639-646.
9. Moosvi AR, Khaja F, Villanueva L, et al. Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol 1992;20:1482-1489.
10. Hochman JS, Boland J, Sleeper LA, et al., and the SHOCK Registry Investigators. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Circulation 1995;91:873-881.
11. Bengston JR, Kaplan AJ, Pieper KS, et al. Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era . J Am Coll Cardiol 1992;20:1482-1489.
12. Suryapranata H, van't Hof AWJ, Hoorntje JCA, et al. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998;97:2502-2505.
13. Antoniucci D, Santoro GM, Bolognesse L, et al. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction. Results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) Trial. J Am Coll Cardiol 1998;31:1234-1239.
14. Brener SJ, Barr LA, Burchenal JEB, et al, on behalf of the Reopro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. Circulation 1998;98:734-741.
15. Caputo RP, Ho KKL, Stoler RC, et al. Effect of continuous quality improvement analysis on the delivery of primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 1997;79:1159-1164.
16. Moreno R, López de Sá E, López-Sendón JL, et al. Frequency of left ventricular free wall rupture in patients with acute myocardial infarction treated with primary angioplasty. Am J Cardiol 2000;85:757-760.
17. García E, Elízaga J, Pérez N, et al. Primary angioplasty versus systemic thrombolysis in anterior myocardial infarction. J Am Coll Cardiol 1999;33:605-611.
18. Moreno R, García E, Elízaga J, et al. Resultados de la angioplastia primaria en pacientes con enfermedad multivaso. Rev Esp Cardiol 1998;51:547-555.
19. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Nat Cancer Institute 1959;22:719-748.
20. Pérez N, García E, Serrano JA, et al. Efficacy of invasive strategy for the management of acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol 1999;83:989-993.
21. Gacioch GM, Ellis SG, Lee L, et al. Cardiogenic shock complicating acute myocardial infarction: The use of coronary angioplasty and the integration of the new support devices into patient management. J Am Coll Cardiol 1992;19:647-653.
22. Antoniucci D, Valenti R, Santoro GM, et al. Systematic direct angioplasty and stent supported direct angioplasty therapy for cardiogenic shock complicating acute myocardial infarction: Inhospital and long-term survival. J Am Coll Cardiol 1998;31:294-300.
23. Webb JG, Carere RG, Hilton D, et al. Usefulness of coronary stenting for cardiogenic shock. Am J Cardiol 1997;79:81-84.
24. Lefkovits J, Ivanhoe R, Califf R, et al., EPIC Investigators. Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody (Abciximab) on the acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction. Am J Cardiol 1996;77:1045-1051.
25. Schultz RD, Heuser RR, Hatler C, Frey D. Use of c7E3 Fab in conjunction with primary coronary stenting for acute myocardial infarctions complicated by cardiogenic shock. Cathet Cardiovasc Diagn 1996;39:143-148.
26. Forssel G, Nordlander R, Nyquist O, Schenck-Gustavsson. Intraaortic balloon pumping in the treatment of cardiogenic shock complicating acute myocardial infarction. Acta Med Scand 1979;206:189-192.
27. Hagemeijer F, Laird JD, Haalebes MP, Hugenholtz PG. Effectiveness of intra-aortic balloon pumping without cardiac surgery for patients with severe heart failure secondary to a recent myocardial infarction. Am J Cardiol 1977;40:951-956.
28. Berger PB, Holmes DR, Stebbins AL, et al., for the GUSTO-I investigators. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen activator for occluded coronary arteries (GUSTO-I) Trial. An observational study. Circulation 1997;96:122-127.
29. Hochman JS, Sleeper LA, Webb JG, et al., for the SHOCK investigators. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med 1999;341:625-634.
30. Ellis SG, O'Neill WW, Bates ER, et al. Implications for patient triage from survival and left ventricular functional recovery analyses in 500 patients treated with coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1989;6:1251-1259.